My Prostate Cancer has recurred. How does this change my treatment choices, and are new targeted therapies using...

According to the NCCN Guidelines for Recurrent Prostate Cancer (2023), your treatment options depend on several factors:

1. PSA Monitoring and Imaging:

• The NCCN Guidelines recommend getting a PSA test every 6-12 months for category 1 disease, and more frequently if clinically indicated
• New imaging techniques like PSMA PET scans may be recommended to detect where the cancer has recurred

1. Treatment Options: The American Urological Association (AUA) Guidelines outline several approaches:

• Androgen Deprivation Therapy (ADT)
• Radiation therapy if recurrence is localized
• Clinical trials for new treatments
• Secondary hormone therapy options

1. Biomarker-Directed Therapy: According to the most recent ASCO Guidelines:

• Genetic testing is recommended to identify specific mutations (like BRCA1/2)
• For patients with certain genetic mutations, PARP inhibitors may be an option
• Regular PSA monitoring helps guide treatment decisions and timing

Important considerations: The National Cancer Institute (NCI) emphasizes that treatment choices should be based on:

• Location of recurrence
• Previous treatments received
• PSA doubling time
• Overall health status
• Personal preferences

Always consult with your healthcare team to determine the best approach for your specific situation, as they can evaluate all these factors together.

Would you like me to provide more specific information about any of these treatment options or testing approaches?